BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With advances in computing infrastructure and omics technologi
 es within the market\, biopharma leaders are increasingly adopting multi-
 omics within their workflows to accelerate drug discovery and development
 . In parallel\, technology providers are expanding their multi-omics tool
 kits\, with Illumina announcing a new suite of technologies and Element B
 iosciences raising $277M to develop differentiated products.\n\nThe Inaug
 ural Multi-Omics Based Drug Discovery and Development Summit 2025 has bee
 n positioned as the premier event for industry leaders to discuss the opt
 imum applications of multi-omics in projects from early discovery to reve
 rse translation\, across diverse therapeutic areas including Oncology\, I
 mmunology\, and Neuroscience.\n\nJoin 60+ leaders in Computational Biolog
 y\, Biomarker Discovery\, Translational Research\, and Pathology to uncov
 er case studies on the use of harmonized omics technologies to de-risk cl
 inical trials\, inform patient stratification\, identify biomarkers and n
 ovel targets and evaluate therapeutic response. Ensure your company effec
 tively adopts and applies multi-omic technologies to holistically underst
 and disease biology and accelerate the development of precise small molec
 ule and biologic drugs.\n\nURLs:Tickets: https://go.evvnt.com/3115176-2?p
 id=185Brochure: https://go.evvnt.com/3115176-3?pid=185\n\nTime: 8:30 AM -
  5:00 PM\n\nPrices:Conference Only Pass - Industry Pricing: USD 2499.00\,
 Conference Only Pass - Discounted Pricing: USD 2099.00\,Conference Only P
 ass - Solution and Service Prodiver: USD 3199.00\n\nSpeakers: Aarash Bord
 bar\, Co-Founder\, Chief Technology Officer\, Sinopia Biosciences\, Adam 
 Freund\, Founder and Chief Executive Officer\, Arda Therapeutics\, Andrew
  Parton\, Associate Director - Data Science\, MultiOmic Health\, Anjali R
 ao\, Senior Scientist - Bioinformatics\, Gilead Sciences\, Bryan Linggi\,
  Senior Director - Translational Medicine\, AnaptysBio\, Elsa Molina\, Di
 rector\, Single-Cell and Spatial Omics Core\, Salk Institute of Biologica
 l Studies\, Frank Cheng\, Director\, Bioinformatics\, Sonoma Biotherapeut
 ics\, James Yurkovich\, Chief Technology Officer\, Phenome Health\, Juan 
 Henao\, Senior Scientist\, Lipidomics and Metabolomics\, BPGBio Inc.\, Ki
 ana Aran\, Associate Professor\, UC San Diego\, Koichi Hashikawa\, Princi
 pal Scientist - Computational\, Johnson and Johnson\, Luke Khoury\, Resea
 rcher\, Northeastern University\, Meilan He\, Senior Scientist\, Poseida 
 Therapeutics\, Priyank Patel\, Principal Scientist\, Boehringer Ingelheim
 \, Sanjeev Ranade\, Assistant Professor\, Sanford Burnham Prebys\, Si Wu\
 , Senior Principal Scientist\, Amgen\, Todd DeSantis\, Vice President\, I
 nformatics\, Resilient Biotics\n
DTEND:20251002T170000
DTSTAMP:20260512T231941Z
DTSTART:20251001T083000
LOCATION:The Westin San Diego Bayview\, 1051\, Columbia Street\, San Diego
 \, California\, 92101\,
SEQUENCE:0
SUMMARY:With advances in computing infrastructure and omics technologies w
 ithin the market\, biopharma leaders are increasingly adopting multi-omic
 s within...
UID:3c092493-7fb2-481c-bdb4-e1b1b244e1e6
END:VEVENT
END:VCALENDAR